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The stereochemical outcome of the conjugate addition reactions of 
2-acetylindole enolates to unsaturated phenylglycinol-derived 
oxazolopiperidone lactams 1a-f is studied. After reduction of the 2-
acylindole carbonyl group, the Michael adduct cis-6 underwent a  
Lewis acid-promoted intramolecular α-amidoalkylation, 
enantioselectively leading to the tetracyclic ring system of the 
indole alkaloid ervitsine. 
Introduction 
Phenylglycinol-derived oxazolopiperidone lactams have proven 
to be versatile scaffolds that allow the regio- and stereocontrolled 
introduction of substituents at the different positions of the 
piperidine ring, thus providing access to enantiopure piperidines 
bearing virtually any type of substitution pattern and also to more 
complex piperidine-containing alkaloids, including indole 
alkaloids.[1] In particular, the stereoselective introduction of carbon 
appendages at the piperidine 4-position by conjugate addition 
reactions requires the activation of this position, which can be 
accomplished by generation of a conjugated carbon-carbon double 
bond taking advantage of the lactam carbonyl group.  
In previous work we have exploited the conjugate addition of 
lower order alkyl- and arylcyanocuprates to unsaturated 
oxazolopiperidone lactams for the enantioselective synthesis of cis-
2,4-[2] and cis-3,4-disubstituted piperidines,[3] as well as 2,4-
bridged[2] and cis-3,4-fused piperidine[4] derivatives, including the 
antidepressant drug (–)-paroxetine[5] and synthetic intermediates en 
route to the indole alkaloid (–)-16-episilicine[6] and alkaloids of the 
madangamine group.[7] 
Similarly, stereocontrolled conjugate addition reactions of 
sulfur-stabilized nucleophiles and indoleacetic ester enolates have 
been successfully employed as the key steps in enantioselective 
formal syntheses of uleine[8] and Strychnos alkaloids.[9,10] 
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Results and Discussion 
We report herein the conjugate addition of 2-acetylindole 
enolates to unsaturated phenylglycinol-derived oxazolopiperidone 
lactams and the subsequent construction of the tetracyclic 
framework of the indole alkaloid ervitsine by closure of the seven-
membered ring by intramolecular α-amidoalkylation on the indole 






























a) Stereoselective conjugate addition
(bond formed: C14 C15)
b) Intramolecular -amidoalkylation
(bond formed: C5 C7)  
Scheme 1. Synthetic strategy.  
As the starting unsaturated lactams we selected lactams 1a-f 
(Figure 1 and Scheme 2), all of them bearing an ethyl substitutent 
at the 8-position of the oxazolopiperidone system. The preparation 
of 3,8a-cis lactams 1a-d[3,6,8] has previously been reported. The 
new 3,8a-trans lactams 1e and 1f were prepared from the known 
lactams 2a[11] and 2b[11], via the respective seleno derivatives 3a 
and 3b, as outlined in Scheme 2.  
 
Figure 1. Unsaturated oxazolopiperidone lactams. 
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Table 1. Conjugate addition reactions of 2-acetylindoles to unsaturated lactams 1a-d. 
 
Entry Lactam Indole (equiv.) Time R1 R2 Product H7−H8 
cis/trans ratio 
Yield (%)[a] 
1 1a 4a (1.2) 16 h H Me 5 1:2 24 
2 1a 4b (1.2) 10 h H H 6 1:3 30 
3 1a 4b (2.5) 12 h H H 6 1:2.3 56 
4 1a 4b (5.0) 24 h H H 6 1:2.3 68 
5 1a 4b (5.0) 3 h H H 6 1:1.3 73 
6 1b 4a (1.2) 23 h CO2Bn Me 7 3:1 42 
7 1c 4b (1.2) 16 h CO2Me H 8 3:1 38 
8 1b 4b (1.2) 16 h CO2Bn H 9 4:1 46 
9 1b 4b (5.0) 5h CO2Bn H 9 4:1 90 
10 1d 4b (5.0) 4 h CO2tBu H 10 5:1 87 
[a] For the relative configuration of the epimerizable C-6 stereocenter, see the Experimental Section 
 
 
Scheme 2. Preparation of unsaturated lactams 1e and 1f. 
Table 1 summarizes the results obtained in the conjugate 
addition reactions of 2-acetylindole enolates 4a and 4b to 
unsaturated lactams 1a-d. The initial experiments were carried out 
using the enolate of 2-acetyl-1-methylindole (4a). Starting from 
unsaturated lactam 1a, which lacks the activating electron-
withdrawing benzyloxycarbonyl group, the use of a slight excess 
(1.2 equiv.) of the nucleophile (entry 1) led to the expected adducts 
5 in low yield (24%) as a 1:2 epimeric mixture of C-7/C-8 cis/trans 
isomers. A similar result was observed using the enolate of 2-
acetylindole (4b): compound 6 was obtained in 30% yield as a C-
7/C-8  cis/trans epimeric mixture in a 1:3 ratio (entry 2). The yield 
grew progressively higher as the excess of the nucleophile was 
increased (entries 3 and 4), reaching 68% when using 5 equiv. of 
enolate.  
The relative configuration of the cis and trans isomers was 
evident from the shielding of the oxazolopiperidone 6-carbon in the 
13C NMR spectrum of cis-6 (δ 37.9 ppm; compare with δ 42.0 ppm 
in trans-6) exerted by the axial ethyl substituent at C-8. 
The facial selectivity of the conjugate addition reactions to 
lactam 1a (R1 = H) can be accounted for by considering that the 
addition of stabilized anions to α,β-unsaturated carbonyl 
compounds is a reversible process that in the case of 5-substituted 
5,6-dihydro-2-pyridones leads to the thermodynamically more 
stable trans-4,5-disubstituted derivative.[12] Accordingly, in the 
reaction of lactam 1a with acetylindole 4b an increase of the ratio 
of the isomer cis-6 was observed when the reaction was quenched 
after a short reaction time (Table 1, entry 5).  
In clear contrast from the stereochemical standpoint, similar 
conjugate addition reactions from the activated lactams 1b-d, 
which bear an additional activating alcoxycarbonyl substituent, led 
to the respective adducts 7-10 as diastereoisomeric mixtures in 
which the C-7/C-8  cis isomers predominated (entries 6-10).[13] As 
in the above lactam 1a, the use of a 5 equiv. excess of nucleophile 
in these reactions resulted in higher yields, lactams 9 and 10 being 
formed in 90% (compare entries 8 and 9) and 87% yield (entry 10), 
respectively, even after shorter reaction times. 
The C-7/C-8 cis relative configuration in the major isomer cis-9 
was confirmed by its conversion [H2, Pd(OH)2; then toluene at 
reflux] to cis-6, the minor isomer obtained from lactam 1a (Scheme 
3).  
 
Scheme 3. Removal of the benzyloxycarbonyl substituent. 
On the other hand, the predominance of the cis isomer in the 
conjugate addition to lactams 1b-d (R1 = CO2R)  can be 
rationalized by considering that in these cases the equilibration 
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takes place to a lesser extent as a consequence of the higher 
stability of the initially formed adduct (a 1,3-dicarbonyl enolate). 
The process would then occur mainly under stereoelectronic 
control,[14]  which involves an axial approach of the nucleophile to 
the electrophilic carbon of the conjugate double bond from the exo 
face of the bicyclic system as depicted in Figure 2. In fact, 
irreversible conjugate additions (for instance, of organocuprates) to 
unsaturated oxazolopiperidone lactams (1a-f or related lactams) 
have been reported to occur under stereoelectronic control with 
complete exo facial selectivity. [15]   
 
Figure 2.  Stereoelectronic control in the conjugate addition. 
 A similar stereoelectronically controlled facial 
stereoselectivity was observed in the conjugate addition of the 
enolate of 4b to the C-8 epimeric 3,8a-trans lactams 1e and 1f 
(Figure 2), the respective exo adducts cis-11 and trans-12 being 
formed as the major isomers (Scheme 4). 
 
Scheme 4. Conjugate addition reactions of 2-acetylindole to unsaturated 
lactams 1e and 1f; In= indolyl. 
To study the closure of the seven-membered ring characteristic 
of ervitsine, we initially selected lactam trans-6. However, all 
attempts to promote the cyclization under a variety of acidic 
conditions (TiCl4, CH2Cl2, reflux; BF3.Et2O, CH2Cl2, reflux; HCl, 
MeOH or C6H6) resulted in failure. Enamide 13[16] and the 8a-
epimer (14) and the 8,8a-diastereoisomer (15) of trans-6 were the 
only isolable products (Scheme 5).[17] The stereochemistry of 14 
and 15 was confirmed when these compounds were unambiguously 
prepared from trans-12 and cis-11, respectively, by debenzylation 
[H2, Pd(OH)2] followed by decarboxylation.  
 
Scheme 5.  
Taking into account that the isolation of compounds 13-15 
clearly indicated that the N-acyl iminium cation[18] had been 
formed, the failure of the cyclization was attributed to the 
deactivating effect of the carbonyl group conjugated with the 
indole ring. For this reason, acylindole trans-6 was converted to 
alcohol 16 and then to the indolylethyl derivative 18 by 
hydrogenolysis of the corresponding acetate 17. 
The desired cyclization upon the indole 3-position did not occur 
from 16 or 18 either, under a variety of acidic conditions, only 
extensive decomposition being observed. 
Bearing in mind that the closure of the seven-membered ring of 
ervitsine and analogs has been successfully achieved by a related 
intramolecular iminium ion cyclization,[19] at this point we 
reasoned that conformational factors could be responsible for the 
reluctance of the above C-7/C-8 trans derivatives to undergo 
intramolecular α-amidoalkylation: cyclization would involve an 
encumbered conformation in which both C-7 and C-8 substituents 
should be axial. To confirm this hypothesis, we decided to study 
related α-amidoalylation reactions from C-7/C-8 cis lactams.  
However, no cyclized products were detected upon treatment of 
cis-6 with TiCl4, the 8a-epimer of cis-6 being the only isolable 
product.[20] As in the above C-7/C-8 trans series, 2-acylindole cis-6 
was reduced to alcohol 19, and then converted to indolylethyl 
derivative 21 via the corresponding acetate 20 (Scheme 6).
 
 
Scheme 6. Access to the tetracyclic ring system of ervitsine. 
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Although alcohol 19 underwent extensive decomposition upon 
acidic treatment, to our delight, when the reduced derivative 21 
was treated with TiCl4 in refluxing CH2Cl2, tetracycle 22 was 
isolated in 58% yield.  
Conclusions 
In conclusion, conjugate addition reactions of 2-acetylindole 
enolates to phenylglycinol-derived unsaturated δ-lactams allow the 
stereocontrolled formation of C–C bonds at the piperidine 4-
position. Depending on the absence or presence of an additional 
electron-withdrawing substituent conjugated with the C–C double 
bond, the reaction predominantly leads to either trans- or cis-4,5-
disubtituted enantiopure 2-piperidone derivatives, respectively. 
The synthetic potential of the resulting Michael adducts has been 
demonstrated with the enantioselective construction of the 
tetracyclic ring system of ervitsine, a minor indole alkaloid isolated 
from Pandaca boiteaui[21] that lacks the characteristic tryptamine 
moiety present in most monoterpenoid indole alkaloids. Starting 
from an appropriate lactam bearing a C-8 substituent precursor of 
the exocyclic methylene group, the strategy developed here, 
involving a stereoselective conjugate addition and an 
intramolecular α-amidoalkylation as the key steps (see Scheme 1), 
may be applied to the enantioselective synthesis of ervitsine.[22] 
Experimental Section 
General: Flash chromatography was carried out on SiO2 (silica gel 
60, SDS, 0.04-0.06 mm) or (when indicated) using a cartridge 
containing amine functionalized silica. Optical rotations were 
measured on Perkin-Elmer 241 polarimeter. High resolution mass 
spectra (HMRS; LC/MSD TOF Agilent Technologies) were 
performed by Serveis Científico-Tècnics, Barcelona. Microanalyses 
(Carlo Erba 1106 analyzer) were performed by Centre 
d’Investigació i Desenvolupament (CSIC), Barcelona. Only 
noteworthy IR absorptions (cm-1; Perkin-Elmer 1600) are listed. 
NMR spectra were recorded at 200, 300, 400 or 500 MHz (1H) and 




a]pyridine (3a): Lithium bis(trimethylsilyl)amide (9.4 mL of a 1.0 
M solution in THF, 9.4 mmol) was slowly added at −78 ºC to a 
solution of lactam 2a[11] (1.08 g, 4.24 mmol) in anhydrous THF (50 
mL), and the resulting mixture was stirred for 90 min. Then, benzyl 
chloroformate (710 µL, 4.24 mmol) and, after 2 h of continuous 
stirring at −78 ºC, a solution of C6H5SeCl (1.14 g, 5.09 mmol) in 
anhydrous THF (5 mL) were added. The mixture was stirred for 2 
h and poured into saturated aqueous NH4Cl. The aqueous layer was 
extracted with EtOAc, and the combined organic extracts were 
dried and concentrated. Flash chromatography (hexane to 4:1 
hexane–EtOAc) of the resulting oil afforded the corresponding 
selenides 3a as a mixture of C-6 epimers (1.40 g, 62%). Data for 
3a: Orange oil. 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 0.74 (t, J = 
7.5 Hz, 3H, CH3 ethyl), 0.80 (t, J = 7.3 Hz, 3H, CH3 ethyl), 1.12-
1.18 (m, 1H, CH2 ethyl), 1.12-1.22 (m, 1H, CH2 ethyl), 1.57-1.95 
(m, 3H, CH2 ethyl, H-7, H-8), 1.61-1.72 (m, 2H, CH2 ethyl, H-8), 
1.83-2.00 (m, 2H, H-7), 2.33 (dd, J = 13.8, 2.1 Hz, 1H, H-7), 3.71 
(dd, J = 9.0, 7.8 Hz, 1H, H-2), 3.78 (dd, J = 9.0, 7.5 Hz, 1H, H-2), 
4.34 (d, J = 8.1 Hz, 1H, H-8a), 4.37 (dd, J = 9.0, 7.5 Hz, 1H, H-2), 
4.46 (dd, J = 9.0, 7.8 Hz, 1H, H-2), 4.67 (d, J = 7.8 Hz, 1H, H-8a), 
5.20 (d, J = 6.9 Hz, 1H, CH2C6H5), 5.20 (s, 2H, CH2C6H5), 5.24 (d, 
J = 6.9 Hz, 1H, CH2C6H5), 5.25 (d, J = 7.8 Hz, 1H, H-3), 5.30 (t, J 
= 7.5 Hz, 1H, H-3), 7.18-7.70 (m, 30H, ArH) ppm. 13C NMR 
(100.6 MHz, CDCl3, 25 ºC): δ = 10.5, 10.7 (CH3 ethyl), 23.7, 24.0 
(CH2 ethyl), 32.5, 35.2 (C-7), 37.8, 39.3 (C-8), 54.2, 55.6 (C-6), 
58.8 (C-3), 67.7, 67.8 (CH2C6H5), 72.1, 72.3 (C-2), 92.0, 92.3 (C-
8a), 125.7, 126.1 (C-o), 126.6, 126.7 (C-m), 127.3, 127.5 (C-p), 
127.9, 128.0 (C-o), 128.0, 128.1 (C-p), 128.3, 128.4 (C-m), 128.5, 
128.6 (C-o), 128.7, 128.8 (C-m), 129.3, 129.5 (C-i), 135.0, 135.1 
(C-i), 138.0 (C-p), 138.5, 138.7 (C-i), 164.5, 164.9 (NCO), 169.9, 




a]pyridine (3b): Operating as in the above preparation of 3a, from 
lactam 2b[11] (2 g, 7.90 mmol) in THF (100 mL), LiHMDS (17.3 
mL of a 1.0 M solution in THF), benzyl chloroformate (1.2 mL, 8.6 
mmol), and C6H5SeCl (1.70 g, 8.80 mmol) in THF (20 mL), a 
mixture of C-6 epimeric selenides (3.46 g, 82%) was obtained. 
Pure isomers were isolated after a subsequent flash 
chromatography (hexane to 9:1 hexane−EtOAc). Data for 3b 
(higher Rf epimer): Orange oil; [α]22D  = – 84.0 (c = 0.5, CHCl3). IR 
(film): ν = 1664, 1724 cm-1. 1H NMR (300 MHz, CDCl3, 25 ºC): δ 
= 0.82 (t, J = 7.5 Hz, 3H, CH3 ethyl), 1.29-1.38 (m, 1H, CH2 ethyl), 
1.53-1.63 (m, 1H, CH2 ethyl), 1.72-1.81 (m, 1H, H-8), 1.88-2.02 
(m, 1H, H-7), 1.99 (dd, J = 12.9, 5.1 Hz, 1H, H-7), 3.73 (dd, J = 
8.7, 6.9 Hz, 1H, H-2), 4.45 (t, J = 8.7 Hz, 1H, H-2), 4.60 (d, J = 5.4 
Hz, 1H, H-8a), 5.09 (d, J = 12.3 Hz, 1H, CH2C6H5), 5.32 (d, J = 
12.3 Hz, 1H, CH2C6H5), 5.56 (t, J = 8.1 Hz, 1H, H-3), 7.13-7.55 
(m, 15H, ArH) ppm. 13C NMR (75.4 MHz, CDCl3, 25 ºC): δ = 11.4 
(CH3 ethyl), 23.3 (CH2 ethyl), 33.6 (C-7), 35.9 (C-8), 54.2 (C-6), 
58.1 (C-3), 67.4 (CH2C6H5), 70.8 (C-2), 87.8 (C-8a), 125.6 (C-o), 
126.7 (C-m), 127.3 (C-p), 128.1 (C-o), 128.2 (C-m), 128.4 (C-p), 
128.6 (C-o), 129.5 (C-m), 135.2 (C-p), 138.5 (C-i), 139.5 (C-i), 
167.1 (NCO), 169.4 (COO) ppm. C29H29NO4Se (534.51): calcd. C 
65.17, H 5.47, N 2.62; found C 65.19, H 5.58, N 2.54.  Data for 3b 
(lower Rf epimer): Orange oil; [α]22D  = – 22.0 (c = 0.5, CHCl3). IR 
(film): ν = 1661, 1732 cm-1. 1H NMR (300 MHz, CDCl3, 25 ºC): δ 
= 0.81 (t, J = 7.5 Hz, 3H, CH3 ethyl), 1.12-1.23 (m, 1H, CH2 ethyl), 
1.55-1.67 (m, 1H, CH2 ethyl), 2.04 (dd, J = 15.0, 4.2 Hz, 1H, H-7), 
2.22-2.28 (m, 1H, H-8), 2.56 (dd, J = 15.0, 6.6 Hz, 1H, H-7), 3.84 
(dd, J = 8.7, 6.3 Hz, 1H, H-2), 4.34 (dd, J = 8.7, 7.5 Hz, 1H, H-2), 
4.85 (d, J = 4.8 Hz, 1H, H-8a), 5.18 (s, 2H, CH2C6H5), 5.35 (t, J = 
6.8 Hz, 1H, H-3), 7.06-7.47 (m, 15H, ArH) ppm. 13C NMR (75.4 
MHz, CDCl3, 25 ºC): δ = 11.6 (CH3 ethyl), 18.7 (CH2 ethyl), 32.5 
(C-7), 37.2 (C-8), 52.7 (C-6), 58.6 (C-3), 67.9 (CH2C6H5), 71.6 (C-
2), 89.0 (C-8a), 126.5 (C-o), 126.7 (C-m), 127.6 (C-p), 128.1 (C-o), 
128.4 (CHAr), 128.7 (CHAr), 129.4 (CHAr), 135.2 (C-i), 137.7 
(C-i), 139.2 (C-i), 165.1 (NCO), 170.2 (COO) ppm. C29H29NO4Se 
(534.51): calcd. C 65.17, H 5.47, N 2.62; found C 64.81, H 5.64, N 
2.64.   
 
(3R,8R,8aS)-6-(Benzyloxycarbonyl)-8-ethyl-5-oxo-3-phenyl-
3,5,8,8a-tetrahydro-5H-oxazolo[3,2-a]pyridine (1e): A stream of 
ozone gas was bubbled through a cooled (−78 ºC) solution of the 
selenides 3a (161 mg, 0.30 mmol) in anhydrous CH2Cl2 (50 mL) 
until it turned pale blue (5 min). Then, the solution was purged 
with O2, and the temperature was slowly raised to 25 ºC. After 30 
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min of stirring, the mixture was poured intro brine, and the aqueous 
layer was extracted with CH2Cl2. The combined organic extracts 
were dried and concentrated to give unsaturated lactam 1e, which 
due to its instability was used in the next reaction without further 
purification. Data for 1e: Yellow oil. 1H NMR (300 MHz, CDCl3, 
25 ºC): δ = 1.10 (t, J = 7.5 Hz, 3H, CH3 ethyl), 1.57-1.66 (m, 1H, 
CH2 ethyl), 1.81-1.90 (m, 1H, CH2 ethyl), 2.53-2.61 (m, 1H, H-8), 
3.94 (dd, J = 9.0, 6.0 Hz, 1H, H-2), 4.44 (dd, J = 9.0, 6.9 Hz, 1H, 
H-2), 5.10 (d, J = 9.3 Hz, 1H, H-8a), 5.26 (d, J = 5.3 Hz, 1H, 
CH2C6H5), 5.29 (m, 1H, H-3), 5.30 (d, J = 5.3 Hz, 1H, CH2C6H5), 
7.19-7.40 (m, 11H, H-7, ArH) ppm.  
 
(3R,8S,8aS)-6-(Benzyloxycarbonyl)-8-ethyl-5-oxo-3-phenyl-
3,5,8,8a-tetrahydro-5H-oxazolo[3,2-a]pyridine (1f): Operating 
as in the above preparation of 1e, from a mixture of selenides 3b 
(246 mg, 0.46 mmol) in CH2Cl2 (15 mL), unsaturated lactam 1f 
(173 mg, 0.46 mmol) was obtained, which due to instability was 
used in the next reaction without further purification. Data for 1f: 
Orange oil. 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 0.99 (t, J = 7.5 
Hz, 3H, CH3 ethyl), 1.38-1.48 (m, 1H, CH2 ethyl), 1.83-1.92 (m, 
1H, CH2 ethyl), 2.76-2.81 (m, 1H, H-8), 4.00 (dd, J = 8.4, 5.7 Hz, 
1H, H-2), 4.47 (dd, J = 8.4, 6.9 Hz, 1H, H-2), 5.22-5.26 (m, 3H, 
CH2C6H5, H-3), 5.50 (d, J = 5.4 Hz, 1H, H-8a), 7.24-7.62 (m, 11H, 
H-7, ArH) ppm.  
 
General Procedure for the Conjugate Addition Reactions: LDA 
was added to a cooled (–78 ºC) solution of 2-acetylindole (4a or 
4b) in THF, and the mixture was stirred at this temperature for 1 h. 
Then, a solution of unsaturated lactam 1 in THF was added to the 
solution (–78 ºC). The resulting mixture was stirred at room 
temperature until the disappearance of the starting material was 
observed by TLC. The reaction was quenched by the addition of 
saturated aqueous NH4Cl, and the mixture was extracted with 
EtOAc. The combined extracts were dried and concentrated to give 




a]pyridine (trans-5) and its 7S epimer (cis-5): Operating as 
described in the general procedure, from lactam 1a[3b,8] (200 mg, 
0.82 mmol) in THF (30 mL), LDA (0.65 mL of a solution 1.5 M in 
cyclohexane, 0.98 mmol), and a solution of indole 4a (170 mg, 
0.98 mmol) in 30 mL of THF for 16 h, compound 5 was obtained 
as a mixture of C-7 epimers.  Flash chromatography (from 1:1 to 
3:7 hexane–EtOAc) afforded trans-5 (53 mg, 16%) and cis-5 (27 
mg, 8%). Data for trans-5: Yellow foam; [α]22D = − 13.0 (c = 0.5, 
CHCl3). IR (film): ν = 1644, 1661 cm-1. 1H NMR (400 MHz, 
CDCl3, 25 ºC): δ = 1.07 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.65-1.89 
(m, 3H, CH2 ethyl, H-8), 2.16 (dd, J = 18.2, 9.2 Hz, 1H, H-6), 2.50-
2.60 (m, 2H,  H-6, H-7), 2.87 (dd, J = 16.2, 7.6 Hz, 1H, CH2CO), 
3.10 (dd, J = 16.2, 5.2 Hz, 1H, CH2CO), 4.05 (s, 3H, NCH3), 4.09 
(d, J = 9.0 Hz, 1H, H-2), 4.18 (dd, J = 9.0, 6.8 Hz, 1H, H-2), 4.73 
(d, J = 7.6 Hz, 1H, H-8a), 4.96 (dd, J = 6.8, 1.2 Hz, 1H, H-3), 7.11 
(s, 1H, H-3 ind), 7.13-7.20 (m, 1H, H-7 ind), 7.26-7.40 (m, 7H, H-
5, H-6 ind, ArH), 7.67 (dd, J = 8.2, 1.2 Hz, 1H, H-4 ind) ppm. 13C 
NMR (100.6 MHz, CDCl3, 25 ºC): δ = 10.2 (CH3 ethyl), 22.7 (CH2 
ethyl), 32.2 (C-7), 37.5 (C-6), 43.7 (CH2CO), 44.8 (C-8), 58.4 (C-
3), 73.9 (C-2), 91.1 (C-8a), 110.3 (C-3 ind), 111.8 (C-7 ind), 120.7 
(C-4 ind), 122.9 (C-6 ind), 125.6 (C-5 ind), 126.2 (C-2 ind), 126.7 
(C-o), 128.6 (C-m), 127.6 (C-p), 134.7 (C-i), 140.2 (C-3a ind), 
141.2 (C-7a ind), 166.7 (NCO), 192.0 (CO) ppm. HRMS calcd. for 
C26H29N2O3 [M+ H]+: 417.2178; found 417.2172. Data for cis-5: 
Yellow foam. 1H NMR (200 MHz, CDCl3, 25 ºC): δ = 1.11 (t, J = 
7.4 Hz, 3H, CH3 ethyl), 1.38-1.63 (m, 1H, CH2 ethyl), 1.87-2.06 (m, 
2H, CH2 ethyl, H-8), 2.33-2.48 (m, 2H, H-6, H-7), 2.94-3.03 (m, 
3H, 2CH2CO, H-6), 4.06-4.22 (m, 2H, H-2), 4.08 (s, 3H, NCH3), 
4.68 (d, J = 9.6 Hz, 1H, H-8a), 4.94 (d, J = 5.8 Hz, 1H, H-3), 7.12-




(trans-6) and its 7S epimer (cis-6): Table 1, entry 4: Operating as 
described in the general procedure, from unsaturated lactam 1a[3b,8] 
(400 mg, 1.64 mmol) in THF (30 mL), LDA (11 mL of a solution 
1.5 M in cyclohexane, 16.5 mmol), a solution of 2-acetylindole 4b 
(1.3 g, 8.2 mmol) in 50 mL of THF for 24 h, compound 6 was 
obtained as a mixture of C-7 epimers. Flash chromatography (from 
1:1 to 3:7 hexane–EtOAc) afforded trans-6 (316 mg, 48%) and cis-
6 (132 mg, 20%). Table 1, entry 5: Operating as above, from 
lactam 1a (296 mg, 1.21 mmol) and acetylindole 4b (970 mg, 6.12 
mmol) for 3 h, pure lactams trans-6 (201 mg, 42 %) and cis-6 (150 
mg, 31 %) were obtained after flash chromatography. Data for 
trans-6: Yellow foam. [α]22D = − 7.0 (c =0.5, CHCl3). IR (film): ν = 
1657, 1735, 3312 cm-1. 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 
1.04 (t, J = 7.2 Hz, 3H, CH3 ethyl), 1.64-1.88 (m, 3H, CH2 ethyl, 
H-8), 2.16 (dd, J = 16.5, 7.6 Hz, 1H, CH2CO), 2.57 (m, 1H, H-7), 
2.68 (dd, J = 16.5, 6.0 Hz, 1H, H-6), 2.79 (dd, J = 16.5, 9.2 Hz, 1H, 
CH2CO), 3.00 (dd, J = 16.5, 4.5 Hz, 1H, H-6), 4.10 (dd, J = 9.0, 
1.2 Hz, 1H, H-2), 4.18 (dd, J = 9.0, 6.6 Hz, 1H, H-2), 4.71 (d, J = 
8.1 Hz, 1H, H-3), 4.98 (d, J = 5.7 Hz, 1H, H-8a), 6.87 (d, J = 1.5 
Hz, 1H, H-3 ind), 7.04-7.08 (m, 1H, H-6 ind), 7.18-7.25 (m, 1H, 
H-5 ind), 7.28-7.41 (m, 7H, ArH, H-4 ind), 10.05 (s, 1H, NH) ppm. 
13C NMR (75.4 MHz, CDCl3, 25 ºC): δ = 10.1 (CH3 ethyl), 22.4 
(CH2 ethyl), 30.8 (C-7), 37.2 (CH2CO), 42.0 (C-6), 44.6 (C-8), 58.3 
(C-3), 73.8 (C-2), 90.7 (C-8a), 109.3 (C-3 ind), 112.5 (C-7 ind), 
120.3 (C-4 ind), 122.6 (C-6 ind), 125.8 (C-5 ind), 126.7 (C-o), 
127.0 (C-3a ind), 127.5 (C-m), 128.5 (C-p), 135.0 (C-7a ind), 137.7 
(C-i), 141.3 (C-2 ind), 167.2 (NCO), 190.4 (CO) ppm. 
C25H26N2O3.1/4 EtOAc (424.52): calcd. C 73.56, H 6.65, N 6.60; 
found C 73.77, H 6.63, N 6.47. Data for cis-6: Yellow foam. [α]22D 
= − 70.4 (c = 0.5, CHCl3). IR (film): ν = 1657, 1735, 3325 cm-1. 1H 
NMR (300 MHz, CDCl3, 25 ºC): δ = 1.10 (t, J = 7.3 Hz, 3H, CH3 
ethyl), 1.45-1.54 (m, 1H, CH2 ethyl), 1.89-2.03 (m, 2H, CH2 ethyl, 
H-8), 2.45 (m, 2H, CH2CO), 3.00 (m, 3H, 2H-6, H-7), 4.04 (dd, J = 
9.3, 4.3 Hz, 1H, H-2), 4.18 (dd, J = 9.3, 6.9 Hz, 1H, H-2), 4.68 (d, 
J = 9.3 Hz, 1H, H-3), 4.94 (d, J = 5.7 Hz, 1H, H-8a), 6.87 (d, J = 
1.5 Hz, 1H, H-3 ind), 7.11-7.36 (m, 9H, ArH, H ind), 7.68 (dd, J = 
8.1, 0.9 Hz, 1H, H-4 ind), 9.50 (s, 1H, NH) ppm. 13C NMR (75.4 
MHz, CDCl3, 25 ºC): δ = 11.3 (CH3 ethyl), 21.2 (CH2 ethyl), 29.0 
(C-7), 36.5 (CH2CO), 37.9 (C-6), 43.6 (C-8), 59.4 (C-3), 73.8 (C-
2), 90.2 (C-8a), 109.4 (C-3 ind), 112.4 (C-7 ind), 120.8 (C-4 ind), 
122.8 (C-6 ind), 126.2 (C-5 ind), 126.3 (C-o), 127.2 (C-3a ind),  
127.4 (C-m), 128.4 (C-p), 135.0 (C-7a ind), 137.6 (C-i), 141.3 (C-2 
ind), 166.8 (NCO), 190.7 (CO) ppm. C25H26N2O3.1/2 H2O 





hexahydro-5H-oxazolo[3,2-a]pyridine (cis-7): Operating as 
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described in the general procedure,  from the crude of unsaturated 
lactam 1b[3a] (500 mg, 1.32 mmol) in THF (10 mL), LDA (0.8 mL 
of a solution 2.0 M in THF–ether, 1.6 mmol), and a solution of 
indole 4a (274 mg, 1.58 mmol) in 20 mL of THF for 23 h, 
compound 7 was obtained as a mixture of diastereoisomers. Flash 
chromatography (from 9:1 to 1:1 hexane–EtOAc) afforded cis-7 
(228 mg, 32%) and trans-7 (mixture of C-6 epimers; 76 mg, 10%). 
Data for cis-7: Yellow foam. [α]22D  = − 69.8 (c = 1.0, CHCl3). IR 
(film): ν = 1660, 1735 cm-1. 1H NMR (300 MHz, CDCl3, 25 ºC): δ 
= 1.02 (t, J = 7.5 Hz, 3H, CH3 ethyl), 1.40-1.50 (m, 1H, CH2 ethyl), 
1.85-1.94 (m, 1H, CH2 ethyl), 2.42-2.51 (m, 1H, H-8), 2.95 (dd, J = 
16.2, 11.1 Hz, 1H, CH2CO), 3.13 (dd, J = 16.2, 2.4 Hz, 1H, 
CH2CO), 3.15-3.19 (m, 1H, H-7), 3.45 (d, J = 0.3 Hz, 1H, H-6), 
4.01-4.12 (m, 1H, H-2), 4.05 (s, 3H, NCH3), 4.18 (dd, J = 9.0, 6.9 
Hz, 1H, H-2), 4.67 (d, J = 9.6 Hz, 1H, H-8a), 4.95 (t, J = 5.7 Hz, 
1H, H-3), 5.06 (d, J = 12.3 Hz, 1H, CH2C6H5), 5.13 (d,  J = 12.3 
Hz, 1H, CH2C6H5), 7.15-7.40 (m, 14H, ArH, H-ind), 7.68 (dd, J = 
7.8 Hz, 1H, H-ind) ppm. 13C NMR (75.4 MHz, CDCl3, 25 ºC): δ = 
11.1 (CH3 ethyl), 20.8 (CH2 ethyl), 32.2 (NCH3), 33.1 (C-7), 37.4 
(CH2CO), 40.2 (C-8), 53.4 (C-6), 59.7 (C-3), 66.9 (CH2C6H5), 74.0 
(C-2), 90.3 (C-8a), 110.5 (C-3 ind), 114.4 (C-7 ind), 120.9 (C-5 
ind), 122.9 (C-4 ind), 125.6 (CAr), 126.3 (CHAr), 126.4 (CHAr), 
127.5 (CAr), 127.8 (CHAr), 128.0 (CAr), 128.4 (CHAr), 128.5 
(CHAr), 134.5 (C-i), 135.6 (C-2 ind), 140.3 (C-3a ind), 140.6 (C-
7a ind), 162.1 (NCO), 169.5 (COO), 190.8 (CO) ppm. 
C34H34N2O5.1/3 EtOAc (579.73): calcd. C 73.18, H 6.37, N 4.83; 




oxazolo[3,2-a]pyridine (cis-8) and its 6R,7S diastereoisomer 
(trans-8): Operating as described in the general procedure, from 
the crude of unsaturated lactam 1c[3a] (657 mg, 2.18 mmol) in THF 
(10 mL), LDA (3.84 mL of a solution 1.5 M in THF, 5.76 mmol), 
and a solution of 2-acetylindole 4b (417 mg, 2.61 mmol) in 30 mL 
of THF for 16 h, compound 8 was obtained as a mixture of 
diastereoisomers. Flash chromatography (hexane to 9:1 hexane–
EtOAc) afforded cis-8 (290 mg, 29%) and trans-8 (90 mg, 9%). 
Data for cis-8: Yellow foam. [α]22D = − 65.3 (c = 1.0,  CHCl3). IR 
(film): ν = 1655, 1736, 3324 cm-1. 1H NMR (300 MHz, CDCl3, 25 
ºC): δ = 1.11 (t, J = 7.6 Hz, 3H, CH3 ethyl), 1.44-1.54 (m, 1H, CH2 
ethyl), 1.89-1.99 (m, 1H, CH2 ethyl), 2.46-2.55 (m, 1H, H-8), 2.93 
(dd, J = 16.2, 11.1 Hz, 1H, CH2CO), 3.12 (dd, J = 16.2, 2.7 Hz, 1H, 
CH2CO), 3.17-3.21 (m, 1H, H-7), 3.41 (d, J = 10.5 Hz, 1H, H-6), 
3.60 (s, 3H, OCH3), 4.06 (dd, J = 9.0, 1.5 Hz, 1H, H-2), 4.20 (dd, J 
= 9.0, 7.2 Hz, 1H, H-2), 4.68 (d, J = 9.9 Hz, 1H, H-8a), 4.97 (dd, J 
= 7.2, 1.5 Hz, 1H, H-3), 7.13-7.40 (m, 9H, ArH, H-ind), 7.68 (dd, J 
= 8.1, 0.9 Hz, 1H, H-4 ind), 9.27 (s, 1H, NH) ppm. 13C NMR (75.4 
MHz, CDCl3, 25 ºC): δ = 11.2 (CH3 ethyl), 20.0 (CH2 ethyl), 33.4 
(C-7), 35.8 (CH2CO), 40.1 (C-8), 52.4 (C-6), 53.1 (OCH3), 59.7 
(C-3), 74.0 (C-2), 90.3 (C-8a), 109.6 (C-3 ind), 112.5 (C-7 ind), 
121.0 (C-4 ind), 122.9 (C-5 ind), 126.5 (C-6 ind), 126.6 (C-o), 
127.3 (C-2 ind), 127.5 (C-m), 128.3 (C-p), 134.8 (C-i), 137.7 (C-3a 
ind), 140.6 (C-7a ind), 162.4 (NCO), 170.2 (COO), 190.1 (CO) 
ppm. C27H28N2O5.1/2 EtOAc (504.58): calcd. C 69.03, H 6.39, N 
5.55; found C 68.99, H 6.16, N 5.59.  Data for trans-8: Yellow 
foam. [α]22D = + 3.6 (c = 1.0, CHCl3). IR (film): ν = 1656, 1737, 
3310 cm-1. 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 1.11 (t, J = 7.5 
Hz, 3H, CH3 ethyl), 1.63-1.75 (m, 1H, CH2 ethyl), 1.75-1.87 (m, 
1H, CH2 ethyl), 1.96-2.01 (m, 1H, H-8), 2.89-2.98 (m, 1H, H-7), 
3.02-3.06 (m, 2H, CH2CO), 3.52 (d, J = 7.2 Hz, 1H, H-6), 3.69 (s, 
3H, OCH3), 4.12 (dd, J = 9.3, 1.2 Hz, 1H, H-2), 4.21 (dd, J = 9.3, 
6.6 Hz, 1H, H-2), 4.83 (d, J = 8.4 Hz, 1H, H-8a), 4.98-5.00 (m, 1H, 
H-3), 7.01 (d, J = 1.8 Hz, 1H, H-3 ind), 7.11-7.45 (m, 8H, ArH, H-
ind), 7.66 (d, J = 8.1 Hz, 1H, H-4 ind), 9.32 (s, 1H, NH) ppm. 13C 
NMR (75.4 MHz, CDCl3, 25 ºC): δ = 10.3 (CH3 ethyl), 23.1 (CH2 
ethyl), 33.7 (C-7), 41.1 (CH2CO), 44.7 (C-8), 52.6 (OCH3), 54.9 
(C-6), 59.0 (C-3), 73.8 (C-2), 90.4 (C-8a), 109.6 (C-3 ind), 112.3 
(C-7 ind), 120.9 (C-4 ind), 122.9 (C-5 ind), 126.8 (C-6 ind), 126.6 
(C-o), 127.3 (C-2 ind), 127.5 (C-p), 128.5 (C-m), 134.8 (C-i), 
137.6 (C-3a ind), 140.8 (C-7a ind), 162.7 (NCO), 170.0 (COO), 
190.1 (CO) ppm. C27H28N2O5.3/4 H2O (474.04): calcd. C 68.41, H 




oxazolo[3,2-a]pyridine (cis-9) and its 6S,7S diastereoisomer 
(trans-9): Operating as described in the general procedure,  from 
the crude of unsaturated lactam 1b[3a] (1.55 g, 4.11 mmol) in THF 
(50 mL), LDA (27.4 mL of a solution 1.5 M in THF, 41.1 mmol), 
and a solution of 2-acetylindole 4b (3.27 g, 20.5 mmol) in 100 mL 
of THF for 5 h, compound 9 was obtained as a mixture of 
diastereoisomers. Flash chromatography (hexane to 1:1 hexane–
EtOAc) afforded cis-9 (accompanied by trace amounts of the C-6 
epimer; 1.53 g, 69%) and trans-9 (457 mg, 21%). Data for cis-9: 
Yellow foam. [α]22D = − 87.0 (c = 0.2, CHCl3). IR (film): ν = 1655, 
1735, 3320 cm-1. 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 1.02 (t, J 
= 7.6 Hz, 3H, CH3 ethyl), 1.40-1.50 (m, 1H, CH2 ethyl), 1.83-1.94 
(m, 1H, CH2 ethyl), 2.42-2.51 (m, 1H, H-8), 2.92 (dd, J = 16.2, 
11.1 Hz, 1H, CH2CO), 3.10 (dd, J = 16.2, 2.7 Hz, 1H, CH2CO), 
3.16 (m, 1H, H-7), 3.47 (d, J = 1.2 Hz, 1H, H-6), 4.03 (dd, J = 9.0, 
1.5 Hz, 1H, H-2), 4.19 (dd, J = 9.0, 7.2 Hz, 1H, H-2), 4.67 (d, J = 
9.6 Hz, 1H, H-8a), 4.97 (dd, J = 7.2, 1.5 Hz, 1H, H-3), 5.03 (d, J = 
16.8 Hz, 1H, CH2C6H5), 5.08 (d, J = 16.8 Hz, 1H, CH2C6H5), 7.12-
7.41 (m, 14H, ArH), 7.69 (dd, J = 8.4, 1.2 Hz, 1H, H-4 ind), 9.22 (s, 
1H, NH) ppm. 13C NMR (75.4 MHz, CDCl3, 25 ºC): δ = 11.1 (CH3 
ethyl), 20.7 (CH2 ethyl), 33.4 (C-7), 35.8 (CH2CO), 40.1 (C-8), 
53.1 (C-6), 59.5 (C-3), 66.7 (CH2C6H5), 73.8 (C-2), 90.0 (C-8a), 
109.3 (C-3 ind), 112.6 (C-7 ind), 120.6 (C-2 ind), 122.5 (C-6 ind), 
126.1 (C-5 ind), 126.2 (C-4 ind), 126.9, 127.2, 127.5, 127.7, 127.9, 
128.1 (C-o, m, p), 134.6 (C-3a ind), 135.2 (C-7a ind), 140.5 (C-i), 
137.7 (C-i), 162.2 (COO), 169.2 (NCO), 189.9 (CO) ppm. 
C33H32N2O5.1/4 EtOAc (558.65): calcd. C 73.10, H 6.13, N 5.01; 
found C 73.08, H 6.00, N 4.99. Data for trans-9: Yellow foam. 1H 
NMR (400 MHz, CDCl3, 25 ºC): δ = 0.99 (t, J = 7.6 Hz, 3H, CH3 
ethyl), 1.71-2.04 (m, 3H, CH2 ethyl, H-8), 2.87-3.18 (m, 3H, 
2CH2CO, H-7), 3.56 (d, J = 5.6 Hz, 1H, H-6), 4.01-4.20 (m, 2H, 
H-2), 4.71 (d, J = 8.4 Hz, 1H, H-8a), 4.97 (d, J = 6.0 Hz, 1H, H-3), 
5.09 (d, J = 11.6 Hz, 1H, CH2C6H5), 5.14 (d, J = 11.6 Hz, 1H, 
CH2C6H5), 6.95 (d, J = 1.6 Hz, 1H, H-3 ind), 7.12-7.41 (m, 13H, 
ArH), 7.65 (d, J = 7.6 Hz, 1H, H-4 ind), 9.09 (bs, 1H, NH) ppm. 
13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 10.4 (CH3 ethyl), 23.1 
(CH2 ethyl), 34.9 (C-7), 41.1 (CH2CO), 44.7 (C-8), 55.0 (C-6), 58.9 
(C-3), 67.3 (CH2C6H5), 73.8 (C-2), 90.4 (C-8a), 109.7 (C-3 ind), 
112.3 (C-7 ind), 120.9 (C-2 ind), 123.0 (C-6 ind), 126.4 (C-5 ind), 
126.5 (C-4 ind), 126.9-128.6 (C-o, m, p), 134.8 (C-3a ind), 137.5 
(C-7a ind), 140.6 (C-i), 140.8 (C-i), 162.7 (COO), 169.9 (NCO), 
190.0 (CO) ppm.  
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(3R,6R,7R,8S,8aR)-6-(tert-Butoxycarbonyl)-8-ethyl-7-[2-(2-
indolyl)-2-oxoethyl]-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro-5H-
oxazolo[3,2-a]pyridine  (cis-10): Operating as described in the 
general procedure, from crude unsaturated lactam 1d[6] (1.0 g, 2.90 
mmol) in THF (50 mL), LDA (19.5 mL of a solution 1.5 M in 
cyclohexane, 29 mmol), and a solution of 2-acetylindole 4b (2.3 g, 
14.5 mmol) in 100 mL of THF for 4 h, compound 10 was obtained 
as a mixture of diastereoisomers. Flash chromatography (hexane to 
1:1 hexane–EtOAc) afforded cis-10 (1.17 g, 80%) and trans-10 
(mixture of C-6 epimers; 230 mg, 7%). Data for cis-10: Yellow 
foam. [α]22D = − 21.5 (c = 0.2, CHCl3). IR (KBr): ν = 1662, 1728, 
2958 cm-1. 1H NMR (400 MHz, CDCl3, 25 ºC): δ = 1.11 (t, J = 7.6 
Hz, 3H, CH3 ethyl), 1.34 [s, 9H, (CH3)3C], 1.43-1.52 (m, 1H, CH2 
ethyl), 1.88-1.96 (m, 1H, CH2 ethyl), 2.56 (ddd, J = 13.6, 9.2, 4.8 
Hz, 1H, H-8), 2.91 (dd, J = 16.0, 10.8 Hz, 1H, CH2CO), 3.08 (dd, J 
= 16.0, 2.4 Hz, 1H, CH2CO), 3.20 (m, 1H, H-7), 3.30 (s, 1H, H-6), 
4.04 (d, J = 8.4 Hz, 1H, H-2), 4.19 (dd, J = 8.4, 7.2 Hz, 1H, H-2), 
4.66 (d, J = 9.6 Hz, 1H, H-8a), 4.97 (d, J = 6.4 Hz, 1H, H-3), 7.12-
7.40 (m, 9H, ArH), 7.68 (d, J = 8.4 Hz, 1H, H-4 ind), 9.36 (bs, 1H, 
NH) ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 11.2 (CH3 
ethyl), 20.8 (CH2 ethyl), 27.8 [C(CH3)3], 32.9 (C-7), 36.0 (CH2CO), 
40.3 (C-8), 54.4 (C-6), 59.6 (C-3), 74.1 (C-2), 81.9 [C(CH3)3], 90.3 
(C-8a), 109.5 (C-3 ind), 112.3 (C-7 ind), 121.0 (C-5 ind), 123.0 (C-
6 ind), 126.5 (C-o), 126.6 (C-2 ind), 127.4 (C-m), 128.4 (C-p), 
134.9 (C-3a ind), 137.5 (C-7a ind), 140.8 (C-i), 162.5 (NCO), 
168.3 (COO), 190.1 (CO) ppm. HRMS calcd. for C30H35N2O5  [M 




oxazolo[3,2-a]pyridine (cis-11): Operating as described in the 
general procedure,  from crude unsaturated lactam 1e (161 mg, 
0.43 mmol) in THF (10 mL), LDA (2.86 mL of a solution 1.5 M in 
THF, 4.3 mmol), and a solution of 2-acetylindole 4b (342 mg, 2.15 
mmol) in 15 mL of THF for 20 h, compound 11 was obtained as a 
mixture of diastereoisomers. Flash chromatography (9:1 hexane–
EtOAc to EtOAc) afforded cis-11 (110 mg, 48%) and trans-11 (1:1 
mixture of C-6 epimers; 32 mg, 14%). Data for cis-11: Yellow 
foam. [α]22D  = − 101.1 (c = 1.2, CHCl3). IR (KBr): ν = 1656, 1735 
cm-1. 1H NMR (300 MHz, CDCl3, 25 ºC): δ = 0.98 (t, J = 7.5 Hz, 
3H, CH3 ethyl), 1.61 (m, 1H, CH2 ethyl), 1.76 (m, 1H, CH2 ethyl), 
1.91 (m, 1H, H-8), 2.91 (m, 1H, H-7), 3.12 (dd, J = 5.4, 2.4 Hz, 2H, 
CH2CO), 3.67 (d, J = 9.3 Hz, 1H, H-6), 3.73 (dd, J = 9.0, 7.8 Hz, 
1H, H-2), 4.49 (dd, J = 9.0, 7.8 Hz, 1H, H-2), 4.93 (d, J = 8.4 Hz, 
1H, H-8a), 5.04 (d, J = 12.3 Hz, 1H, CH2C6H5), 5.13 (d, J = 12.3 
Hz, 1H, CH2C6H5), 5.29 (t, J = 7.8 Hz, 1H, H-3), 7.12-7.37 (m, 
14H, ArH, H-ind), 7.67 (d, J = 8.1 Hz, 1H, H-4 ind), 9.21 (bs, 1H, 
NH) ppm. 13C NMR (75.4 MHz, CDCl3, 25 ºC): δ = 9.9 (CH3 
ethyl), 21.5 (CH2 ethyl), 33.4 (C-7), 38.6 (CH2CO), 40.3 (C-8), 
55.4 (C-6), 58.7 (C-3), 67.4 (CH2C6H5), 72.6 (C-2), 90.6 (C-8a), 
109.4 (C-3 ind), 112.3 (CHind), 121.0 (CHind), 123.1 (CHind), 
125.7 (CHAr), 126.5 (CHAr), 127.4 (C-i), 127.6 (CHAr), 128.0 
(CHAr), 128.2 (CHAr), 128.4 (CHAr), 128.8 (CHAr), 134.8 (C-i), 
135.2 (C-2 ind), 137.4 (C-3a ind), 138.6 (C-7a), 164.1 (NCO), 
170.1 (COO), 190.0 (CO) ppm. C33H32N2O5 (536.62): calcd. C 




5H-oxazolo[3,2-a]pyridine (trans-12): Operating as described in 
the general procedure,  from the crude of unsaturated lactam 1f (1 g, 
2.65 mmol) in THF (50 mL), LDA (26.5 mL of a solution 1 M in 
THF, 26.5 mmol), and a solution of 2-acetylindole 4b (2.11 g, 
13.25 mmol) in 100 mL of THF for 5 h, compound 12 was 
obtained as a mixture of diastereoisomers. Flash chromatography 
(9:1 hexane–EtOAc to EtOAc) afforded trans-12 (9:1 mixture of 
C-6 epimers; 1.02 g, 72%) and cis-12 (mixture of C-6 epimers; 211 
mg, 14%). Data for trans-12 (major 6S-epimer): Yellow foam. IR 
(film): ν = 1655, 1736, 3324 cm-1. 1H NMR (400 MHz, CDCl3, 25 
ºC): δ = 0.95 (t, J = 7.2 Hz, 3H, CH3 ethyl), 1.26-1.41 (m, 1H, CH2 
ethyl), 1.64-1.71 (m, 1H, CH2 ethyl), 2.23-2.31 (m, 1H, H-8), 2.98-
3.04 (m, 1H, H-7), 3.09 (dd, J = 12.4, 6.0 Hz, 1H, CH2CO),  3.13 
(dd, J = 12.4, 6.4 Hz, 1H, CH2CO), 3.66 (d, J = 8.8 Hz, 1H, H-6), 
3.86 (dd, J = 8.8, 6.8 Hz, 1H, H-2), 4.45 (dd, J = 8.8, 8.0 Hz, 1H, 
H-2), 5.09 (d, J = 9.2 Hz, 1H, H-8a), 5.16 (d, J = 12.5 Hz, 1H, 
CH2C6H5), 5.19 (d, J = 12.5 Hz, 1H, CH2C6H5), 5.33 (t, J = 7.6 Hz, 
1H, H-3), 7.10 (d, J = 1.4 Hz, 1H, H-3 ind), 7.15-7.42 (m, 13H, 
ArH, H-ind), 7.69 (t, J = 8.0 Hz, 1H, H-ind), 9.09 (bs, 1H, NH) 
ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 11.3 (CH3 ethyl), 
19.9 (CH2 ethyl), 33.1 (C-7), 40.5 (CH2CO), 42.1 (C-8), 53.8 (C-6), 
58.8 (C-3), 67.2 (CH2C6H5), 72.3 (C-2), 88.0 (C-8a), 109.5 (C-3 
ind), 112.2 (C-7 ind), 121.1 (C-4 ind), 123.2 (C-5 ind), 125.6 (C-6 
ind), 126.3, 126.7, 127.8, 128.1, 128.3, 128.4, 128.8, (C-o, C-m, C-
p, C-3a ind), 134.7 (C-2 ind), 135.5 (C-7a ind), 139.1 (C-i), 166.0 
(NCO), 169.6 (COO), 190.3 (CO) ppm. HRMS calcd. for 
C33H32N2NaO5  [M + Na]+: 559.2203; found 559.2207. Data for 
trans-12 (minor 6R-epimer): 1H NMR (400 MHz, CDCl3, 25 ºC): δ 
= 1.00 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.30-1.42 (m, 2H, CH2 ethyl), 
3.15-3.20 (m, 2H, H-7, H-8), 3.25 (dd, J = 16.0, 7.2 Hz, 1H, 
CH2CO), 3.30 (dd, J = 16.0, 5.6 Hz, 1H, CH2CO), 3.74 (dd, J = 8.7, 
7.6 Hz, 1H, H-2), 3.78 (d, J = 5.6 Hz, 1H, H-6), 4.52 (t, J = 8.4 Hz, 
1H, H-2), 5.07 (d, J = 12.4 Hz, 1H, CH2C6H5), 5.13 (d, J = 12.4 Hz, 
1H, CH2C6H5), 5.16 (masked, 1H, H-8a), 5.38 (t, J = 7.6 Hz, 1H, 
H-3), 7.00 (d, J = 1.4 Hz, 1H, H-3 ind), 7.10-7.42 (m, 13H, ArH, 
H-ind), 7.68 (t, J = 8.6 Hz, 1H, H-ind), 9.07 (bs, 1H, NH) ppm. 13C 
NMR (100.6 MHz, CDCl3, 25 ºC): δ = 11.6 (CH3 ethyl), 19.5 (CH2 
ethyl), 32.0 (C-7), 38.4 (CH2CO), 39.6 (C-8), 50.5 (C-6), 58.1 (C-
3), 67.3 (CH2C6H5), 71.9 (C-2), 87.6 (C-8a), 109.5 (C-3 ind), 112.2 
(C-7 ind), 121.1 (C-4 ind), 123.2 (C-5 ind), 125.6 (C-6 ind), 126.6, 
127.5, 128.4, 128.5, 128.6, 128.8, 128.9 (C-o, C-m, C-p, C-3a ind), 
135.1 (C-2 ind), 134.8 (C-7a ind), 137.3 (C-i), 164.8, (NCO), 169.2 
(COO), 190.1. 
 
Conversion of cis-9 to cis-6: A solution of cis-9 (200 mg, 0.43 
mmol) in EtOAc (10 mL) containing Pd(OH)2 (20 mg) was 
hydrogenated with vigorous stirring at room temperature and 
atmospheric pressure for 24 h. The catalyst was removed by 
filtration, and the solvent was evaporated to give an oil, which was 
dissolved in toluene (30 mL). The resulting solution was heated at 
reflux for 16 h and concentrated to dryness. The residue was 





Operating as above, from trans-12 (900 mg, 1.68 mmol), 30% 
Pd(OH)2 (270 mg) in EtOAc (50 mL), and then refluxing in 
toluene (100 mL), compound 14 was obtained (452 mg, 67%) after 
column chromatography (hexane to 1:1 hexane−EtOAc). Data for 
14: Yellow foam. [α]22D = − 21.6 (c = 0.5, CHCl3). IR (KBr): 1649, 
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3312  cm-1. 1H NMR (400 MHz, CDCl3, 25 ºC): δ = 1.01 (t, J = 7.4 
Hz, 3H, CH3 ethyl), 1.21-1.28 (m, 1H, CH2 ethyl), 1.71-1.79 (m, 
1H, CH2 ethyl), 2.18 (ddd, J = 14.0, 6.0, 4.8 Hz, 1H, H-8), 2.36 (dd, 
J = 18.4, 3.2 Hz, 1H, CH2CO), 2.63 (dd, J = 18.4, 6.4 Hz, 1H, 
CH2CO), 2.84 (m, 1H, H-7), 3.09-3.11 (m, 2H, H-6), 3.79 (dd, J = 
8.8, 7.6 Hz, 1H, H-2), 4.48 (t, J = 8.8 Hz, 1H, H-2), 5.23 (d, J = 4.4 
Hz, 1H, H-8a), 5.30 (t, J = 7.6 Hz, 1H, H-3), 7.14-7.41 (m, 9H, 
ArH), 7.69 (d, J = 8.0 Hz, 1H, H-4 ind), 9.35 (bs, 1H, NH) ppm. 
13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 11.6 (CH3 ethyl), 18.7 
(CH2 ethyl), 29.6 (C-7), 33.7 (CH2CO), 40.7 (C-8), 41.9 (C-6), 58.3 
(C-3), 72.2 (C-2), 88.0 (C-8a), 109.5 (C-3 ind), 112.3 (C-7 ind), 
121.1 (C-5 ind), 123.1 (C-6 ind), 126.0 (C-o), 126.7 (C-2 ind), 
127.7 (C-m), 128.9 (C-p), 134.9 (C-3a ind), 137.5 (C-7a ind), 139.6 
(C-i), 168.1 (NCO), 190.7 (CO) ppm. HRMS cald. for C25H27N2O3 




Operating as above, from cis-11 (620 mg, 1.15 mmol), 20% 
Pd(OH)2 (124 mg) in MeOH (40 mL), and then refluxing in 
toluene (70 mL), compound 15 was obtained (288 mg, 62%) after 
column chromatography (hexane to 1:1 hexane−EtOAc). Data for 
15: Yellow foam. [α]22D = − 74.7 (c = 0.67, CHCl3). IR (KBr): ν = 
1648   cm-1. 1H NMR (400 MHz, CDCl3, 25 ºC): δ = 1.08 (t, J = 
7.6 Hz, 3H, CH3 ethyl), 1.45-1.54 (m, 1H, CH2 ethyl), 1.75-1.90 (m, 
2H, CH2 ethyl, H-8), 2.54-2.66 (m, 2H, H-6, H-7), 2.90 (m, 1H, H-
6), 2.97 (d, J = 11.8 Hz, 1H, CH2CO), 3.08 (d, J = 11.8 Hz, 1H, 
CH2CO), 3.80 (t, J = 8.4 Hz, 1H, H-2), 4.56 (t, J = 8.4 Hz, 1H, H-
2), 4.78 (d, J = 9.2 Hz, 1H, H-8a), 5.35 (t, J = 8.0 Hz, 1H, H-3), 
7.12-7.41 (m, 9H, ArH, H ind), 7.66 (d, J = 8.4 Hz, 1H, H-ind), 
9.26 (bs, 1H, NH) ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 
11.5 (CH3 ethyl), 22.1 (CH2 ethyl), 29.0 (C-7), 36.1 (CH2CO), 37.4 
(C-6), 44.0 (C-8), 58.3 (C-3), 72.4 (C-2), 90.9 (C-8a), 109.4 (C-3 
ind), 112.3 (C-7 ind), 121.1 (C-4 ind), 123.0 (C-5 ind), 125.9 (C-o), 
126.7 (C-6 ind), 127.4 (C-2 ind), 127.8 (C-m), 129.0 (C-p), 135.0 
(C-i), 137.5 (C-3a), 139.7 (C-7a), 168.3 (NCO), 190.9 (CO) ppm. 
HRMS calcd. for C25H27N2O3 [M + H]+: 403.2016; found: 
403.2018. C25H26N2O3.1/2 H2O (411.50): calcd. C 72.97, H 6.61, N 




(16): NaBH4 (117 mg, 3.11 mmol) was slowly added to a solution 
of trans-6 (128 mg, 0.31 mmol) in MeOH (11 mL) at 0 ºC. The 
mixture was stirred at 0 ºC for 1 h and the temperature was slowly 
raised to 25 ºC. The mixture was concentrated, water was added, 
and the aqueous layer was extracted with Et2O. The combined 
organic extracts were dried and concentrated to give a foam, which 
was chromatographed (1:1 hexane−EtOAc to EtOAc) to afford 
alcohol 16 as a mixture of epimers (115 mg, 90%). Data for 16 
(higher Rf epimer): Yellow foam. 1H NMR (400 MHz, CDCl3, 25 
ºC): δ = 0.80 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.37-1.62 (m, 5H, CH2 
ethyl, CH2CHOH, H-7, H-8), 1.88 (dd, J = 16.8, 7.2 Hz, 1H, H-6), 
1.97 (dd, J = 10.4, 8.0 Hz, 1H, CH2CHOH), 2.22 (bs, 1H, OH), 
2.43 (dd, J = 16.8, 4.4 Hz, 1H, H-6), 3.92 (dd, J = 8.8, 1.6 Hz, 1H, 
H-2), 3.96 (dd, J = 8.8, 6.0 Hz, 1H, H-2), 4.20 (d, J = 7.6 Hz, 1H, 
H-8a), 4.59 (m, 1H, CHOH), 4.77 (d, J = 5.2 Hz, 1H, H-3), 6.20 (s, 
1H, H-3 ind), 7.02-7.27 (m, 8H, ArH, H-ind), 7.50 (d, J = 7.2 Hz, 
1H, H-4 ind), 9.16 (bs, 1H, NH) ppm. 13C NMR (100.6 MHz, 
CDCl3, 25 ºC): δ = 9.5 (CH3 ethyl), 21.2 (CH2 ethyl), 31.2 (C-7), 
37.4 (C-6), 40.5 (CH2CHOH), 44.4 (C-8), 58.7 (C-3), 66.6 
(CHOH), 73.7 (C-2), 90.5 (C-8a), 98.9 (C-3 ind), 111.3 (C-7 ind), 
119.6 (C-5 ind), 120.3 (C-4 ind), 121.7 (C-6 ind), 126.5 (C-o), 
127.6 (C-p), 128.0 (C-2 ind), 128.5 (C-m), 136.0 (C-3a ind), 140.8 
(C-7a ind), 141.2 (C-i), 167.6 (NCO) ppm.  Data for 16 (lower Rf 
epimer): Yellow foam. 1H NMR (400 MHz, CDCl3, 25 ºC): δ = 
0.91 (t, J = 7.3 Hz, 3H, CH3 ethyl), 1.19-1.26 (m, 1H, CH2CHOH), 
1.41-1.45 (m, 1H, H-8), 1.49-1.59 (m, 1H, CH2 ethyl), 1.68 (ddd, J 
= 14.4, 7.2, 4.0 Hz, 1H, CH2 ethyl), 1.88-1.92 (m, 1H, H-6), 1.95-
2.04 (m, 2H, CH2CHOH, H-7), 2.21 (bs, 1H, OH), 2.55 (dd, J = 
16.4, 4.8 Hz, 1H, H-6), 3.91-3.97 (m, 2H, H-2), 4.29 (d, J = 9.2 Hz, 
1H, H-8a), 4.73 (d, J = 9.2 Hz, 1H, CHOH), 4.78 (d, J = 4.8 Hz, 
1H, H-3), 6.18 (s, 1H, H-3 ind), 7.04 (dd, J = 6.4, 1.2 Hz, 1H, H-7 
ind), 7.08 (dd, J = 7.6, 1.6 Hz, 1H, H-5 ind), 7.09-7.24 (m, 6H, 
ArH, H-6 ind), 7.53 (d, J = 8.0 Hz, 1H, H-4 ind), 9.24 (bs, 1H, NH) 
ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 9.3 (CH3 ethyl), 
20.5 (CH2 ethyl), 29.2 (C-7), 36.5 (C-6), 39.7 (CH2CHOH), 44.2 
(C-8), 59.0 (C-3), 64.4 (CHOH), 73.7 (C-2), 90.6 (C-8a), 97.5 (C-3 
ind), 111.1 (C-7 ind), 119.4 (C-5 ind), 120.2 (C-4 ind), 121.3 (C-6 
ind), 126.4 (C-o), 127.6 (C-p), 128.2 (C-2 ind), 128.6 (C-m), 135.8 




DMAP (8 mg, 0.06 mmol) and Ac2O (140 µL, 1.48 mmol) were 
added to a cooled (0 ºC) solution of alcohols 16 (135 mg, 0.34 
mmol) in CH2Cl2 and pyridine (2 mL, 4:1). The mixture was stirred 
at rt for 4h, diluted with CHCl3, and successively washed with 1 N 
aqueous HCl and saturated aqueous NaHCO3. The organic solution 
was dried and concentrated to afford an epimeric mixture of 
acetates 17 (86 mg, 57%), which was used in the next reaction 
without further purification. Data for 17: Yellow foam. 1H NMR 
(400 MHz, CDCl3, 25 ºC): δ = 0.87 (t, J = 7.2 Hz, 3H, CH3 ethyl), 
1.04 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.12-1.17 (m, 2H, H-7), 1.23-
2.21 (m, 8H, CH2 ethyl, CH2CHO, H-8), 2.20 (s, 3H, CH3CO), 
2.25 (s, 3H, CH3CO), 2.55-2.63 (m, 2H, CH2CHO), 2.34 (dd, J = 
14.0, 6.8 Hz, 1H, H-6), 3.32-3.49 (m, 3H, H-6), 4.01 (d, J = 9.0 Hz, 
1H, H-2), 4.05 (d, J = 8.8 Hz, 1H, H-2), 4.07 (d, J = 8.8 Hz, 1H, H-
2), 4.17 (dd, J = 9.0, 6.8 Hz, 1H, H-2), 4.47-4.54 (m, 3H, CH2CHO, 
H-8a), 4.70 (d, J = 8.4 Hz, 1H,  H-8a), 4.90 (d, J = 6.4 Hz, 1H, H-
3), 4.95 (d, J = 6.0 Hz, 1H, H-3), 6.33 (s, 1H, H-3 ind), 6.44 (s, 1H, 
H-3 ind), 7.10 (dd, J = 14.8, 7.2 Hz, 1H, H-ind), 7.17 (dd, J = 14.8, 
7.2 Hz, 1H, H-ind), 7.07-7.59 (m, 18H, ArH, H-ind), 8.30 (bs, 1H, 
NH) ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 9.6, 9.9 (CH3 
ethyl), 15.2, 15.3 (CH2 ethyl), 21.5, 21.6 (COCH3), 30.3, 30.9 (C-
7), 36.9, 37.4 (C-6), 44.8, 44.9 (CH2CO), 58.7, 58.7 (C-3), 64.3, 
64.5 (CHOAc), 73.9, 74.0 (C-2), 90.7, 91.1 (C-8a), 100.4, 102.1 
(C-3 ind), 110.9, 111.0 (C-7 ind), 119.8, 119.9 (C-5 ind), 120.4, 
120.5 (C-4 ind), 121.8, 122.1 (C-6 ind), 126.4, 126.5 (C-o), 127.5 
(C-p), 128.0, 128.2 (C-2 ind), 128.6 (C-m), 135.9, 136.2 (C-3a ind), 
137.7, 139.4 (C-3a ind), 141.2, 141.3 (C-i), 166.6 (NCO), 166.8 
(COO) ppm.   
 
(3R,7R,8S,8aR)-8-Ethyl-7-[(2-indolyl)ethyl]-5-oxo-3-phenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (18): A 
solution of acetates 17 (160 mg, 0.36 mmol) in EtOAc (25 mL) 
containing 20% Pd-C (17 mg) was hydrogenated at rt for 4 days at 
atmospheric pressure. The catalyst was removed by filtration, and 
the solvent was evaporated to give an oil. Flash chromatography 
(from 9:1 to 4:1 hexane−EtOAc) afforded 18 (70 mg, 50%). Data 
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for 18: Yellow foam. 1H NMR (400 MHz, CDCl3, 25 ºC): δ = 0.99 
(t, J = 7.6 Hz, 3H, CH3 ethyl), 1.63-2.18 (m, 7H, CH2 ethyl, H-7, 
H-8, indCH2CH2, indCH2CH2), 2.49-2.64 (m, 1H, indCH2CH2), 
2.53 (dd, J = 15.0, 6.0 Hz, 1H, H-6), 2.77 (ddd, J = 15.0, 9.6, 4.8 
Hz, 1H, H-6), 4.06 (dd, J = 9.2, 1.2 Hz, 1H, H-2), 4.16 (dd, J = 9.2, 
6.8 Hz, 1H, H-2), 4.63 (d, J = 8.4 Hz, 1H, H-8a), 4.94 (d, J = 5.6 
Hz, 1H, H-3), 6.20 (s, 1H, H-3 ind), 7.03-7.57 (m, 9H, ArH, H-ind), 
8.22 (bs, 1H, NH) ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 
10.0 (CH3 ethyl), 22.0 (CH2 ethyl), 24.9 (C-6), 33.2 (C-7, 
indCH2CH2), 36.8 (indCH2), 45.1 (C-8), 58.7 (C-3), 74.0 (C-2), 
91.0 (C-8a), 99.5 (C-3 ind), 110.4 (C-7 ind), 119.5 (C-5 ind), 119.7 
(C-4 ind), 121.0 (C-6 ind), 126.4, 126.6 (C-o), 127.6 (C-p), 128.6 
(C-m), 128.7 (C-2 ind), 135.9 (C-3a ind), 138.6 (C-7a ind), 141.2 




(19): Operating as in the above reduction of trans-6, from a 
solution of cis-6 (1.05 mg, 2.60 mmol) in THF (50 mL) and NaBH4 
(148 mg, 3.91 mmol) for 3 h, a foam was obtained. Flash 
chromatography (1:1 hexane−EtOAc to EtOAc) gave two epimeric 
alcohols 19 (higher Rf epimer: 462 mg, 44%; lower Rf epimer: 308 
mg, 29%). Data for 19 (higher Rf epimer): Yellow foam. 1H NMR 
(400 MHz, CDCl3, 25 ºC): δ = 1.03 (t, J = 7.4 Hz, 3H, CH3 ethyl), 
1.38-2.49 (m, 8H, CH2 ethyl, CH2CHOH, H-6, H-7, H-8), 3.14 (bs, 
1H, OH), 3.94-4.04 (m, 2H, H-2), 4.50 (d, J = 8.4 Hz, 1H, H-8a), 
4.81 (m, 2H, CHOH, H-3), 6.29 (s, 1H, H-3 ind), 7.07 (t, J = 7.4 
Hz, 1H, H-ind), 7.13 (t, J = 7.4 Hz, 1H, H-ind), 7.21-7.31 (m, 6H, 
ArH, H-ind), 7.54 (d, J = 7.6 Hz, 1H, H-4 ind), 8.78 (bs, 1H, NH) 
ppm. 13C NMR (100.6 MHz, CDCl3, 25 ºC): δ = 11.2 (CH3 ethyl), 
20.7 (CH2 ethyl), 28.6 (C-7), 35.4 (C-6), 36.9 (CH2CHOH), 43.8 
(C-8), 59.3 (CHOH), 65.3 (C-3), 73.8 (C-2), 90.3 (C-8a), 98.1 (C-3 
ind), 111.0 (C-7 ind), 119.7 (C-5 ind), 120.4 (C-4 ind), 121.7 (C-6 
ind), 126.3 (C-o), 127.6 (C-p), 128.2 (C-2 ind), 128.6 (C-m), 135.7 
(C-3a ind), 141.4 (C-7a ind), 141.6 (C-i), 167.7 (NCO) ppm. Data 
for 19 (lower Rf epimer): Yellow foam. 1H NMR (400 MHz, 
CDCl3, 25 ºC): δ = 0.83 (t, J = 7.4 Hz, 3H, CH3 ethyl), 1.34-2.72 
(m, 8H, CH2 ethyl, CH2CHOH, H-6, H-7, H-8), 3.87-4.00 (m, 2H, 
H-2), 4.51 (d, J = 6.8 Hz, 1H, H-8a), 4.62-4.78 (m, 2H, CHOH, H-
3), 6.27 (s, 1H, H-3 ind), 7.66-7.28 (m, 8H, ArH, H-ind), 7.54 (d, J 
= 7.6 Hz, 1H, H-4 ind), 9.20 (bs, 1H, NH) ppm. 13C NMR (100.6 
MHz, CDCl3, 25 ºC): δ = 11.2 (CH3 ethyl), 20.8 (CH2 ethyl), 29.7 
(C-7), 30.8 (C-6), 38.0 (CH2CHOH), 44.2 (C-8), 59.3 (CHOH), 
68.2 (C-3), 73.8 (C-2), 90.3 (C-8a), 99.2 (C-3 ind), 111.3 (C-7 ind), 
119.6 (C-5 ind), 120.3 (C-4 ind), 121.8 (C-6 ind), 126.3 (C-o), 
127.6 (C-p), 127.9 (C-2 ind), 128.6 (C-m), 136.2 (C-3a ind), 141.0 




Operating as in the above preparation of 17 (reaction time 14 h), 
from alcohols 19 (770 mg, 1.90 mmol), DMAP (8 mg, 0.06 mmol), 
and Ac2O (0.8 mL, 7.61 mmol) in CH2Cl2 and pyridine (12.5 mL, 
4:1), two epimeric acetates 20 (higher Rf epimer: 440 mg, 52%; 
lower Rf epimer: 300 mg, 35%) were obtained after column 
chromatography (hexane to 9:1 hexane-EtOAc). Data for 20 
(higher Rf epimer): Yellow foam. [α]22D  = + 47.5 (c = 1.0, CHCl3). 
IR (KBr): ν = 1641, 1739, 3267 cm-1. 1H NMR (400 MHz, CDCl3, 
25 ºC): δ = 1.11 (t, J = 7.3 Hz, 3H, CH3 ethyl), 1.54-1.63 (m, 1H, 
CH2 ethyl), 1.79 (dd, J = 11.2, 2.8 Hz, 1H, H-6), 1.92-1.99 (m, 2H, 
CH2 ethyl, H-8), 2.10 (s, 3H, CH3CO), 2.26-2.31 (m, 1H, H-7), 
2.35-2.45 (m, 3H, CH2CHO, H-6), 2.54 (d, J = 17.6 Hz, 1H, 
CH2CHO), 3.99 (dd, J = 9.2, 1.2 Hz, 1H, H-2), 4.12 (dd, J = 9.2, 
6.8 Hz, 1H, H-2), 4.62 (d, J = 9.2 Hz, 1H, H-8a), 4.89 (d, J = 6.8 
Hz, 1H, H-3), 6.03 (dd, J = 10.8, 2.4 Hz, 1H, CH2CHO), 6.49 (d, J 
= 2.4 Hz, 1H, H-3 ind), 7.08-7.32 (m, 8H, ArH, H-ind), 7.58 (d, J = 
7.2 Hz, 1H, H-ind), 9.18 (bs, 1H, NH) ppm. 13C NMR (100.6 MHz, 
CDCl3, 25 ºC): δ = 11.0 (CH3 ethyl), 20.6 (CH2 ethyl), 21.1 
(OCH3), 28.9 (C-7), 32.3 (C-6), 37.1 (CH2CHO), 43.7 (C-8), 59.4 
(C-3), 67.5 (CH2CHO), 73.9 (C-2), 90.1 (C-8a), 100.2 (C-3 ind), 
111.4 (C-4 ind), 119.8 (C-5 ind), 120.6 (C-4 ind), 122.3 (C-6 ind), 
126.3 (C-o); 127.5, 127.6 (C-p, C-2 ind), 128.6 (C-m), 136.0 (C-3a 
ind), 137.0 (C-3a ind), 141.5 (C-i), 166.8 (NCO), 171.2 (COO) 
ppm. HRMS calcd. for C27H31N2O4 [M + H]+: 447.2278; found: 
447.2300. Data for 20 (lower Rf epimer): Yellow foam. [α]22D  = + 
4.6 (c = 1.0, CHCl3). IR (KBr): ν = 1645, 1732, 3261   cm-1. 1H 
NMR (400 MHz, CDCl3, 25 ºC): δ = 0.95 (t, J = 7.3 Hz, 3H, CH3 
ethyl), 1.48-1.52 (m, 1H, CH2 ethyl), 1.83-1.95 (m, 3H, CH2 ethyl, 
H-6, H-8), 2.05 (s, 3H, CH3CO), 2.05-2.11 (m, 1H, H-7), 2.31-2.38 
(m, 1H, H-6), 2.35 (d, J = 17.6, 5.6 Hz, 1H, CH2CHO), 2.59 (d, J = 
17.6 Hz, 1H, CH2CHO), 3.40 (dd, J = 8.8, 1.2 Hz, 1H, H-2), 4.13 
(dd, J = 9.2, 8.8 Hz, 1H, H-2), 4.65 (d, J = 9.2 Hz, 1H, H-8a), 4.92 
(d, J = 6.8 Hz, 1H, H-3), 5.96 (dd, J = 9.2, 6.0 Hz, 1H, CH2CHO), 
6.52 (d, J = 2.0 Hz, 1H, H-3 ind), 7.11 (td, J = 7.6, 0.8 Hz, 1H, H-
ind), 7.17-7.32 (m, 7H, ArH, H-ind), 7.59 (d, J = 8.4 Hz, 1H, H-
ind), 8.98 (bs, 1H, NH) ppm. 13C NMR (100.6 MHz, CDCl3, 25 
ºC): δ = 11.4 (CH3 ethyl), 20.9 (CH2 ethyl), 21.2 (OCH3), 30.2 (C-
7), 31.8 (C-6), 37.5 (CH2CHO), 44.2 (C-8), 59.4 (C-3), 69.2 
(CH2CHO), 73.9 (C-2), 90.1 (C-8a), 101.0 (C-3 ind), 111.4 (C-4 
ind), 120.0 (C-5 ind), 120.8 (C-4 ind), 122.6 (C-6 ind), 126.3 (C-o), 
127.5, 127.6 (C-p, C-2 ind), 128.6 (C-m), 135.8 (C-3a ind), 135.9 
(C-3a ind), 141.4 (C-i), 166.7 (NCO), 171.0 (COO) ppm.  HRMS 
calcd. for C27H30N2NaO4 [M + Na]+: 469.2098; found: 469.2113. 
 
(3R,7S,8S,8aR)-8-Ethyl-7-[(2-indolyl)ethyl]-5-oxo-3-phenyl-
2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (21): A 
solution of acetates 20 (150 mg, 0.34 mmol) in EtOAc (20 mL) 
containing 20% Pd(OH)2 (30 mg) was hydrogenated at rt under 
400 psi of pressure for 2 days. The catalyst was removed by 
filtration, and the solvent was evaporated to give a foam. Flash 
chromatography (from 9:1 to 1:1 hexane−EtOAc) afforded 21 (71 
mg, 54%). Data for 21: Yellow foam. [α]22D  = − 42.5 (c = 0.2, 
CHCl3). IR (KBr): ν = 1642 cm-1. 1H NMR (400 MHz, CDCl3, 25 
ºC): δ = 0.98 (t, J = 7.6 Hz, 3H, CH3 ethyl), 1.45-1.56 (m, 2H, CH2 
ethyl, indCH2CH2), 1.82-1.93 (m, 2H, CH2 ethyl, indCH2CH2), 
1.95-2.02 (m, 1H, H-8), 2.09-2.14 (m, 1H, H-7), 2.40 (dd, J = 18.0, 
5.2 Hz, 1H, indCH2), 2.52 (dd, J = 18.0, 2.0 Hz, 1H, indCH2), 2.66 
(ddd, J = 14.8, 10.0, 7.2 Hz, 1H, H-6), 2.95 (ddd, J = 14.8, 10.0, 
4.8 Hz, 1H, H-6), 3.99 (dd, J = 9.2, 1.2 Hz, 1H, H-2), 4.11 (dd, J = 
9.2, 7.2 Hz, 1H, H-2), 4.61 (d, 1H, J = 9.6 Hz, 1H, H-8a), 4.89 (d, 
J = 6.0 Hz, 1H, H-3), 6.24 (d, J = 1.2 Hz, 1H, H-3 ind), 7.05-7.53 
(m, 9H, ArH, H-ind), 8.07 (bs, 1H, NH) ppm. 13C NMR (100.6 
MHz, CDCl3, 25 ºC): δ = 11.3 (CH3 ethyl), 20.9 (CH2 ethyl), 26.5 
(C-6), 27.5 (indCH2CH2), 32.4 (C-7), 36.8 (indCH2), 44.1 (C-8), 
59.3 (C-3), 73.8 (C-2), 90.3 (C-8a), 99.9 (C-3 ind), 110.4 (C-7 ind), 
119.7 (C-5 ind), 119.8 (C-4 ind), 121.2 (C-6 ind), 126.3 (C-o), 
127.5 (C-p), 128.6 (C-m), 128.7 (C-2 ind), 135.9 (C-3a ind), 138.3 
(C-7a ind), 141.5 (C-i), 171.5 (NCO) ppm. HRMS calcd. for 
C25H29N2O2 [M + H]+: 389.2224; found: 389.2224. 
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(1R,5S,13S)-2-[(1R)-2-Hydroxy-1-phenylethyl]-13-ethyl-3-oxo-
2,3,4,5,6,7-hexahydro-3H-1,5-methanoazocine[4,3-b]indole 
(22): TiCl4 (1 mL of a 1.0 M solution in CH2Cl2, 1.0 mmol) was 
added to a solution of 21 (38 mg, 0.10 mmol) in CH2Cl2 (2 mL) at 
rt, and the resulting mixture was heated at reflux for 24 h. TiCl4 (1 
mL of a 1.0 M solution in CH2Cl2, 1.0 mmol) was then added and 
once again after a further 24 h, and the mixture was maintained at 
reflux for an additional 48 h. The mixture was poured into 
saturated aqueous NaHCO3 and extracted with CH2Cl2. The 
combined organic extracts were dried and concentrated, and the 
resulting residue was chromatographed using a cartridge containing 
amine functionalized silica (1:1 hexane-EtOAc to 1:1 EtOAc-
MeOH) to give 22 (22 mg, 58%). Data for 22: Yellow foam. [α]22D  
= − 88.2 (c = 0.5, CHCl3). IR (KBr): ν = 1608, 2926 cm-1. 1H NMR 
(500 MHz, CDCl3, 25 ºC): δ = 0.72 (t, J = 7.5 Hz, 3H, CH3 ethyl), 
1.11 (td, J = 7.5, 7.5, 2.0 Hz, 2H, CH2 ethyl), 1.73 (ddd, J = 14.0, 
7.0, 5.0 Hz, 1H, H-6), 1.95 (dt, J = 14.0, 2.5 Hz, 1H, H-6), 2.05-
2.10 (m, 1H, H-13), 2.42-2.50 (m, 1H, H-5), 2.55 (ddd, J = 16.0, 
5.0, 3.0 Hz, 1H, H-7), 2.75 (d, J = 18.5 Hz, 1H, H-4), 3.00 (dd, J = 
18.5, 8.5 Hz, 1H, H-4), 3.12 (m, 1H, H-7), 3.54 (m, 1H, 
C6H5CHCH2), 3.80-3.83 (m, 1H, C6H5CHCH2), 4.51 (d, J = 5.0 Hz, 
1H, H-1), 5.74 (m, 1H, C6H5CHCH2), 6.98-7.31 (m, 9H, ArH, H-
ind), 8.03 (bs, 1H, NH) ppm. 13C NMR (125.9 MHz, CDCl3, 25 
ºC): δ = 11.7 (CH3 ethyl), 23.0 (CH2 ethyl), 23.4 (C-6), 26.9 (C-7), 
33.8 (C-5), 38.4 (C-4), 41.7 (C-13), 53.0 (C-1), 60.5 (C6H5CHCH2), 
63.2 (C6H5CHCH2), 110.6 (C-12b), 110.8 (C-9), 117.4 (C-12), 
119.6 (C-11), 121.0 (C-10), 127.6 (C-m), 128.1 (C-o), 128.2 (C-7a), 
128.3 (C-p), 133.9 (C-12a), 136.9 (C-8a), 138.5 (C-i), 172.1 
(NCO) ppm. HRMS calcd. for C25H29N2O2 [M + H]+: 389.2224; 
found: 389.2222. 
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